Second-line chemotherapy in malignant pleural mesothelioma: Results of a retrospective multicenter surveyZUCALI, P. A; SIMONELLI, M; LORENZI, E et al.Lung cancer. 2012, Vol 75, Num 3, pp 360-367, issn 0169-5002, 8 p.Article

Triplets versus doublets, with or without cisplatin, in the first-line treatment of stage IIIB―IV non-small cell lung cancer (NSCLC) patients: a multicenter randomised factorial trial (FAST)BONI, C; TISEO, M; LABIANCA, R et al.British journal of cancer. 2012, Vol 106, Num 4, pp 658-665, issn 0007-0920, 8 p.Article

Correlation of cytidine deaminase polymorphisms and activity with clinical outcome in gemcitabine-/platinum- treated advanced non-small-cell lung cancer patientsTIBALDI, C; GIOVANNETTI, E; PETERS, G. J et al.Annals of oncology. 2012, Vol 23, Num 3, pp 670-677, issn 0923-7534, 8 p.Article

Adjuvant chemotherapy for non-small cell lung cancer : Ready for clinical practice?TISEO, M; FRANCIOSI, V; GROSSI, F et al.European journal of cancer (1990). 2006, Vol 42, Num 1, pp 8-16, issn 0959-8049, 9 p.Article

EGFR and EML4-ALK gene mutations in NSCLC: A case report of erlotinib-resistant patient with both concomitant mutationsTISEO, M; GELSOMINO, F; BOGGIANI, D et al.Lung cancer. 2011, Vol 71, Num 2, pp 241-243, issn 0169-5002, 3 p.Article

Multi-target inhibitors in non-small cell lung cancer (NSCLC)TISEO, M; FRANCIOSI, V; ARDIZZONI, A et al.Annals of oncology. 2006, Vol 17, issn 0923-7534, ii55-ii57, SUP2Conference Paper

Case 1. Complete remission to corticosteroids in an octreotide-refractory thymomaTISEO, M; MONETTI, F; FERRARINI, M et al.Journal of clinical oncology. 2005, Vol 23, Num 7, pp 1578-1579, issn 0732-183X, 2 p.Article

ERCC1/BRCA1 expression and gene polymorphisms as prognostic and predictive factors in advanced NSCLC treated with or without cisplatinTISEO, M; BORDI, P; NALDI, N et al.British journal of cancer. 2013, Vol 108, Num 8, pp 1695-1703, issn 0007-0920, 9 p.Article

Phase II study of pemetrexed and carboplatin plus bevacizumab as first-line therapy in malignant pleural mesotheliomaCERESOLI, G. L; ZUCALI, P. A; SOTO-PARRA, H et al.British journal of cancer. 2013, Vol 109, Num 3, pp 552-558, issn 0007-0920, 7 p.Article

Prognostic Value of ¹⁸F-FDG Standard Uptake Value by Integrated PET/CT in the Staging of Malignant Pleural MesotheliomaGENESTRETI, G; MORETTI, A; PICIUCCHI, S et al.Technology in cancer research & treatment (Print). 2012, Vol 11, Num 2, pp 163-167, issn 1533-0346, 5 p.Article